Strive Financial Group’s Novartis NVS Stock Holding History

Strive Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.62K	Hold	55	–	–	﹤0.01%	466
2026 Q1	$8K	Hold	55	–	–	﹤0.01%	449
2025 Q4	$7.58K	Buy	+55	New	+$7.2K	﹤0.01%	421

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Strive Financial Group's NVS Position: Q2 2026 in Review

Strive Financial Group held its Novartis (NVS) position steady in Q2 2026 at 55 shares worth $8.62K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Strive Financial Group first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Strive Financial Group held 55 shares of Novartis worth $8.62K as of Q2 2026.
Strive Financial Group left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #466 holding.
Strive Financial Group first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.